Klein Joseph III's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Sep 4, 2025
- Accession no.
- 0000874015-25-000220
- Filed
- Sep 4, 2025
- Trade date
- Sep 3, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.68M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Klein Joseph IIICIK 0001206369 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2025 | Common Stock | MOption exerciseAcquired | +16,000 | $0.00 | $0 | 16,000 | Indirect | Duplicate filing |
| Sep 3, 2025 | Common Stock | MOption exerciseAcquired | +12,000 | $0.00 | $0 | 28,000 | Indirect | Duplicate filing |
| Sep 3, 2025 | Common Stock | SSaleDisposed | −28,000 | $60.00 | −$1,680,000 | 0 | Indirect | Duplicate filing |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2025 | Common Stock | MOption exerciseDisposed | −12,000 | $0.00 | $0 | 0 | Indirect | Duplicate filing |
| Sep 3, 2025 | Common Stock | MOption exerciseDisposed | −16,000 | $0.00 | $0 | 0 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.